首页> 外文期刊>British journal of ophthalmology >Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome.
【24h】

Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome.

机译:光疗性角膜切除术再治疗复发性角膜侵蚀综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Phototherapeutic keratectomy with an excimer laser is commonly used to treat recurrent corneal erosion syndrome. The aim of this study was to determine the success of a repeat phototherapeutic keratectomy for patients with persistent macroerosions following initial treatment with phototherapeutic keratectomy. METHODS: Eight patients who failed primary phototherapeutic keratectomy for recurrent corneal erosion syndrome were treated with repeat phototherapeutic keratectomy. All patients were treated with a superficial therapeutic ablation profile with a Visx, Nidek, or Summit 193 nm excimer laser. All patients were treated for both their primary treatment and re-treatment by the same surgeon. Retrospective analysis of case records of all patients requiring re-treatment was supplemented with a telephone interview. RESULTS: Over a 5 year period (October 1995 to October 2000) 76 eyes were treated for recurrent erosion syndrome with phototherapeutic keratectomy. All patients had documented macroerosions and had failed previous treatment with a lubricant at night. Eight eyes (11%) continued to have macroerosions after this initial treatment; all opted for re-treatment with phototherapeutic keratectomy. Following re-treatment none reported symptoms consistent with a macroerosion. Six of eight patients (75%) are now symptom free; 2/8 (25%) have an occasional foreign body sensation relieved by lubricants. Follow up ranged from 9-60 months with a mean of 25.5 months. CONCLUSION: Re-treatment with phototherapeutic keratectomy appears to be successful for patients with macroerosions complicating recurrent corneal erosion syndrome who have failed conservative management with ocular lubricants and a primary phototherapeutic keratectomy.
机译:目的:用准分子激光进行光疗性角膜切除术通常用于治疗复发性角膜侵蚀综合征。这项研究的目的是确定在进行光疗性角膜切除术的初始治疗后,持续性宏观侵蚀患者重复进行光疗性角膜切除术的成功率。方法:对8例因复发性角膜侵蚀综合征而导致的原发性光治疗性角膜切除术失败的患者进行了重复的光治疗性角膜切除术治疗。使用Visx,Nidek或Summit 193 nm准分子激光对所有患者进行表面治疗。所有患者均由同一位外科医生进行了主要治疗和再治疗。对所有需要重新治疗的患者的病例记录进行回顾性分析,并辅以电话采访。结果:在5年的时间里(1995年10月至2000年10月),用光疗角膜切除术治疗了76眼复发性糜烂综合征。所有患者均已记录到宏观侵蚀,且先前在夜间使用润滑剂的治疗失败。最初的治疗后,八只眼(11%)继续发生大侵蚀;所有人都选择了光疗性角膜切除术再治疗。再治疗后,没有报道与大侵蚀相符的症状。八名患者中有六名(75%)现在没有症状。 2/8(25%)的润滑剂偶尔会减轻异物感。随访时间为9-60个月,平均25.5个月。结论:对于患有复杂侵蚀的复发性角膜糜烂综合征的复发性眼病患者,使用眼用润滑剂和原发性光治疗性角膜切除术保守治疗失败,光治疗性角膜切除术再治疗似乎是成功的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号